Reaktion #592199

ord-5a20285c89a14c2881d2ae8a47da94c9

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    Sonstigeequipped with an overhead stirrer
  2. 2
    workup.ADDITIONthermocouple, condenser, addition funnel
  3. 3
    TemperaturThe reaction mixture was heated
  4. 4
    workup.ADDITIONwas added
  5. 5
    FiltrationThe resulting mixture was filtered
  6. 6
    Waschenthe top organic layer was washed with brine (50.0 ml)
  7. 7
    EinengenThe organic layer was concentrated to 133 ml
  8. 8
    workup.ADDITIONWater (160 ml) was added to the hot concentrated mixture
  9. 9
    Filtrationfiltered
  10. 10
    WaschenThe cake was washed with a mixture of water and acetonitrile (5:1, 60 ml, 2 times)
  11. 11
    TrocknenThe wet product (82.0 g) was dried in a vacuum oven for 20 h at 45° C.

Vorschrift

To a 1.0 L jacketed reactor equipped with an overhead stirrer, thermocouple, condenser, addition funnel and positive nitrogen pressure was charged acetylbenzodiazepine (40.0 g, 210 mmol, 1.0 eq.), paraformaldehyde prills (6.30 g, 210 mmol, 1.0 eq.), acetonitrile (480 ml) and cyclopentene (86.0 g, 1.26 mol, 6.0 eq.). To the reaction suspension at 12° C. was added boron trifluoride etherate (80.5 g, 567 mmol, 2.7 eq.) in 20 minutes. The reaction mixture was heated. The reaction was monitored by HPLC. After the completion of the reaction, aqueous sodium hydroxide solution (50.0 g NaOH in 250 ml of water) was added. The resulting mixture was filtered, the top organic layer was washed with brine (50.0 ml). The organic layer was concentrated to 133 ml. Water (160 ml) was added to the hot concentrated mixture. The reaction mixture was cooled to ambient temperature and filtered. The cake was washed with a mixture of water and acetonitrile (5:1, 60 ml, 2 times). The wet product (82.0 g) was dried in a vacuum oven for 20 h at 45° C. to afford compound C (52.8 g, yield 93%) as an off-white solid. HPLC (area %): 94.5% C, 3.15% dimeric impurity compound methylene bis[(±)-4,5,6,7,9,9a,10,11,12,12a-decahydrocydopenta[c][1,4]diazepino[6,7,1-ij]quinoline] 1H NMR (300 MHz, DMSO-d6): δ=7.17-6.94 (m, 2H), 6.85-6.73 (m, 1H), 4.81 (d, j=13.7 Hz, 0.4H), 4.56 (d, j=15.3 Hz, 0.6H), 4.35 (d, j=15.3 Hz, 0.6H), 4.16 (m, 0.6H), 3.98 (d, j=13.7 Hz, 0.4H), 3.73 (m, 0.4H), 3.49 (m, 0.4H), 3.30-2.81 (m, 4.6H), 2.63 (m, 1H), 2.21 (m, 2H), 1.98 (m, 4H), 1.57 (m, 2H), 1.27 (m, 2H) ppm. (two conformers at 25° C.) dimeric impurity compound methylene bis[(±)-4,5,6,7,9,9a,10,11,12,12a-decahydrocyclopenta[c][1,4]diazepino[6,7,1-ij]quinoline]: δ=7.08-6.77 (m, 4H), 4.95 (m, 0.6H), 4.39 (m, 4H), 4.05 (m, 0.4H), 3.29-267 (m, 3H), 2.33-1.93 (m, 15H), 1.76-1.20 (m, 6H) ppm. LC/MS: (552 m/z)

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US07781427B2uspto-grants-2010_08